Evidence map›Paper›PMID 34209555›Full record

ArticleCancers2021

An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma.

Colin Watts, Keyoumars Ashkan, Michael D Jenkinson, Stephen J Price, Thomas Santarius, Tomasz Matys, Ting Ting Zhang, Alina Finch, Peter Collins, Kieren Allinson and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Colin WattsInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Keyoumars AshkanDepartment of Neurosurgery, King's College Hospital, London SE5 9RS, UK.
Michael D JenkinsonDepartment of Neurosurgery, The Walton Centre, Liverpool L9 7LJ, UK.
Stephen J PriceAcademic Neurosurgery Department, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0002-7535-3009
Thomas SantariusDepartment of Clinical Neurosciences, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Tomasz MatysDepartment of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Ting Ting ZhangDepartment of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Alina FinchInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Peter CollinsDepartment of Clinical Neurosciences, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Kieren AllinsonDepartment of Histopathology, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.ORCID 0000-0003-3468-2110
Sarah J JefferiesDepartment of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Daniel J ScoffingsDepartment of Clinical Neurosciences, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK.
Athanasios ZisakisDepartment of Neurosurgery, Queen Elizabeth Hospital, Birmingham B15 2WB, UK.
Mark PhillipsCancer Institute, University College London, London WC1E 6DD, UK.
Katharina WanekCancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK.
Paul SmithCancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK.
Laura Clifton-HadleyCancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK.
Nicholas CounsellCancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK.
Cambridge University Hospitals NHS Foundation Trust · GBCancer Research UK · GBQueen Elizabeth Hospital Birmingham · GBKing's College Hospital · GBUniversity College London · GBUniversity of Birmingham · GBUniversity of Cambridge · GBUniversity of Liverpool · GB

Funding

Brain Tumour Charity A11869Cancer Research UK C9221
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

5-aminolevulinic acidBCNU waferschemoRTfeasibility trialglioblastoma

Identifiers

PMID34209555
PMCPMC8267684
OpenAlexW3173322337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.